JOINT FILING AGREEMENTJoint Filing Agreement • June 21st, 2022 • Armistice Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value per share, of Tenax Therapeutics, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
